Chen Yu, Ji Wangquan, Duan Guangcai, Feng Huifen, Zhang Yaodong, Chen Shouhang, Li Zhi, Shen Yuanfang, Wang Chenyu, Zheng Jiaying, Tao Ling, Feng Demin, Liu Wenyi, Sui Meili, Zhang Chao, Yang Haiyan, Chen Shuaiyin, Long Jinzhao, Liu Fang, Wang Zhuangzhuang, Wang Qingmei, Han Shujuan, Dai Bowen, Dang Dejian, Li Xiaolong, Zhu Peiyu, Li Zijie, Li Kang, Li Dong, Li Shuang, Li Guowei, Wang Fang, Jin Yuefei
College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.
Department of Infectious Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, China.
BMJ Open. 2025 Jan 9;15(1):e083958. doi: 10.1136/bmjopen-2024-083958.
The childhood hand, foot and mouth disease (HFMD) sequelae cohort study (HNHFMDCS) is an ambispective cohort study of patients with HFMD based in Henan Province, China, consisting of patients treated in a key hospital for the diagnosis and treatment of HFMD in Henan Province. The study aims to investigate the long-term sequelae of HFMD survivors and to provide a comprehensive understanding of the potential harm caused by this infectious disease.
In the retrospective phase of the cohort study, children diagnosed with HFMD from January 2014 to January 2023 were included, and clinical and demographic information about the patients was collected through a self-developed questionnaire. Patients hospitalised with HFMD since January 2023 were enrolled in the prospective cohort phase of the study, and long-term follow-up will be performed after completion of the baseline investigation (interview and comprehensive physical examination), clinical laboratory examination and biospecimen collection.
For the retrospective analysis of the cohort, a total of 18 705 HFMD cases (11 834 males and 6871 females) were observed between 2014 and 2022, of which 17 202 were mild cases (10 839 males and 6363 females) and 1503 were severe cases (995 males and 508 females). Statistical analysis was performed on the collected clinical examination data, and descriptive statistical methods, including mean value, SD and t-test, were used to compare the intergroup data. All tests were bilateral, and p<0.05 was considered statistically significant. There were significant differences in the hospitalisation duration and clinical examination indicators, such as platelets (PLT), C reactive protein (CRP), aspartate amino transferase (AST), alanine amino transferase (ALT), T lymphocyte subsets (CD3+ and CD3+CD4+) and B lymphocytes (CD19+) between mild and severe patients. The differences in these clinical examination indicators also help to detect changes in the disease in time so as to deeply understand the potential harm and social burden of the disease, and provide strong support for the rehabilitation of patients.
Prospective cohort studies are currently underway, primarily enrolling hospitalised patients with HFMD to participate in our study. After the baseline investigation is completed, we will conduct long-term follow-up of the enrolled cases. In the coming year, we expect to obtain preliminary data on the incidence of sequelae in patients with HFMD 1-10 years after discharge, as well as information on the occurrence of sequelae. This dataset will be updated and expanded on an annual basis to support the continuous monitoring of patient health and disease progression. From HNHFMDCS, the study will provide a comprehensive overview of the potential harm caused by this common infectious disease, assess the social burden caused by this disease and make recommendations for the rehabilitation of survivors and prevention of further disability.
儿童手足口病后遗症队列研究(HNHFMDCS)是一项在中国河南省开展的针对手足口病患者的双向队列研究,研究对象为河南省一家手足口病诊治重点医院收治的患者。该研究旨在调查手足口病幸存者的长期后遗症,并全面了解这种传染病可能造成的危害。
在队列研究的回顾性阶段,纳入了2014年1月至2023年1月期间诊断为手足口病的儿童,并通过自行编制的问卷收集患者的临床和人口统计学信息。自2023年1月起因手足口病住院的患者被纳入研究的前瞻性队列阶段,在完成基线调查(访谈和全面体格检查)、临床实验室检查和生物样本采集后将进行长期随访。
对于队列的回顾性分析,2014年至2022年期间共观察到18705例手足口病病例(男性11834例,女性6871例),其中17202例为轻症病例(男性10839例,女性6363例),1503例为重症病例(男性995例,女性508例)。对收集到的临床检查数据进行了统计分析,采用均值、标准差和t检验等描述性统计方法比较组间数据。所有检验均为双侧检验,p<0.05被认为具有统计学意义。轻症和重症患者在住院时间以及血小板(PLT)、C反应蛋白(CRP)、天冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、T淋巴细胞亚群(CD3+和CD3+CD4+)和B淋巴细胞(CD19+)等临床检查指标方面存在显著差异。这些临床检查指标的差异也有助于及时发现疾病变化,从而深入了解疾病的潜在危害和社会负担,并为患者康复提供有力支持。
前瞻性队列研究目前正在进行,主要招募手足口病住院患者参与我们的研究。在完成基线调查后,我们将对入组病例进行长期随访。在来年,我们期望获得手足口病患者出院后1至10年后遗症发生率的初步数据以及后遗症发生情况的信息。该数据集将每年更新和扩展,以支持对患者健康和疾病进展的持续监测。通过HNHFMDCS,该研究将全面概述这种常见传染病可能造成的危害,评估该疾病造成的社会负担,并为幸存者康复和预防进一步残疾提出建议。